Written by Keen Meds · Reviewed by Licensed Clinical Providers · March 1, 2026
Key Insight: The HPG axis operates as a self-regulating feedback loop: the hypothalamus releases GnRH, which prompts the pituitary to release LH, which signals the testes to produce testosterone. When testosterone levels rise, the hypothalamus and pituitary reduce their output -- maintaining hormonal balance.
Most men who are evaluated for testosterone deficiency receive a blood test that measures testosterone. Many also receive LH and FSH measurements, which can feel puzzling if no one explains what those numbers mean or why they matter. Understanding why LH and FSH are part of a testosterone workup requires understanding the system that controls testosterone production in the first place: the hypothalamic-pituitary-gonadal (HPG) axis. This is the biological control network that links your brain, your pituitary gland, and your testes into a self-regulating hormonal circuit. Understanding how this axis works explains where testosterone deficiency originates, how TRT affects the system, why fertility is affected by exogenous testosterone, and why some men with low testosterone can be treated with alternatives to TRT entirely.
The Three Components of the HPG Axis
The HPG axis is named for its three main anatomical components: the hypothalamus, the anterior pituitary gland, and the gonads (testes, in men).
The hypothalamus is a small region at the base of the brain, below the thalamus and above the brainstem. It serves as the primary link between the nervous system and the endocrine system. In the context of testosterone regulation, its critical function is the pulsatile release of gonadotropin-releasing hormone (GnRH). GnRH is a small peptide hormone secreted in rhythmic bursts -- approximately once every 60 to 120 minutes in normal physiology. This pulsatile pattern is essential: continuous GnRH exposure actually suppresses the system rather than stimulating it (a fact exploited in medications used to treat prostate cancer).
The anterior pituitary gland sits in a bony structure at the base of the skull called the sella turcica, connected to the hypothalamus by a thin stalk through which blood and neural signals travel. When GnRH reaches the pituitary, it stimulates the release of two critical hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These are called gonadotropins because their primary targets are the gonads.
The testes contain two types of hormone-responsive cells. Leydig cells are stimulated by LH and are the primary site of testosterone production in men. Sertoli cells are stimulated by FSH and play a central role in sperm production (spermatogenesis), including providing the physical and nutritional support for developing sperm cells.
The Negative Feedback Loop
The HPG axis is a closed feedback loop. It behaves like a thermostat: when testosterone drops, the system increases the drive to produce more; when testosterone rises, the system reduces its drive.
Elevated testosterone signals back to both the hypothalamus and the anterior pituitary. At the hypothalamus, rising testosterone (and its conversion product, estradiol) reduces the frequency and amplitude of GnRH pulses. At the pituitary, testosterone reduces the sensitivity of gonadotroph cells to GnRH and directly suppresses LH and FSH secretion.
When testosterone falls -- due to testicular failure, aging, or any other cause -- this suppression is released. The hypothalamus increases GnRH pulse frequency and amplitude. The pituitary responds with greater LH and FSH secretion. These elevated gonadotropins drive the testes to produce more testosterone, attempting to restore normal levels.
This is the physiological reason why LH and FSH levels are diagnostically meaningful in the evaluation of testosterone deficiency. They tell you which part of the axis has failed.
Primary vs. Secondary Hypogonadism: Why LH Changes the Diagnosis
When a man has low testosterone, the LH and FSH levels identify where in the axis the problem originates. This distinction has direct implications for treatment.
Primary hypogonadism means the problem is in the testes themselves. The testes are failing to respond adequately to LH stimulation. Because the brain-pituitary axis is intact and responding to the low testosterone signal, LH and FSH are elevated -- the pituitary is sending maximum stimulation but the testes cannot respond. This pattern is seen in Klinefelter syndrome, testicular trauma or torsion, previous chemotherapy or radiation, and some autoimmune conditions.
Secondary hypogonadism means the problem is in the hypothalamus or pituitary. Low testosterone is present, but LH and FSH are low or inappropriately normal -- the brain is not sending adequate stimulation to the testes, so the testes have not ramped up testosterone production. The testes themselves are capable of producing testosterone if properly stimulated; they are simply not receiving the signal. Secondary hypogonadism is caused by pituitary tumors (most commonly prolactinomas), hemochromatosis, obesity-related hypothalamic dysfunction, Kallmann syndrome, or opioid use (opioids suppress GnRH).
Why does this distinction matter? Men with secondary hypogonadism may be candidates for treatments that stimulate the natural axis rather than replacing testosterone directly. Human chorionic gonadotropin (hCG) mimics LH and can stimulate the testes to produce testosterone endogenously. Clomiphene citrate (clomid) is a selective estrogen receptor modulator that blocks estrogen's negative feedback at the hypothalamus and pituitary, causing increased LH and FSH secretion and subsequent testosterone production. These approaches preserve fertility by maintaining testicular function -- a significant advantage for men who have not completed their families.
Men with primary hypogonadism cannot benefit from hCG or clomiphene because the problem is in the testes, not the signaling. They require exogenous testosterone replacement.
How TRT Affects the HPG Axis
When a man starts testosterone replacement therapy, he is introducing exogenous testosterone -- testosterone from outside the body. The HPG axis responds as it would to any source of testosterone: it recognizes elevated blood levels and suppresses the axis.
GnRH pulse frequency decreases. LH and FSH production fall, often to very low or undetectable levels. With LH absent, Leydig cells are no longer stimulated and endogenous testosterone production ceases. With FSH absent, Sertoli cell activity diminishes and spermatogenesis is substantially impaired.
This suppression of spermatogenesis is the mechanism by which TRT reduces fertility. It is predictable, expected, and relevant to discuss with any man who may want biological children. The suppression is also generally reversible after stopping TRT -- but recovery takes time, typically 6 to 18 months, and in some men may be incomplete.
Men who want to maintain fertility while on testosterone therapy can add hCG to their regimen. hCG maintains LH-like stimulation of the Leydig cells and helps preserve testicular volume and some degree of spermatogenesis. This approach does not completely prevent fertility impact but substantially mitigates it.
Frequently Asked Questions
What does it mean if my LH is low along with my testosterone?
Low LH combined with low testosterone indicates secondary hypogonadism -- the hypothalamus or pituitary is not sending adequate stimulation to the testes. This pattern should prompt evaluation for a pituitary cause, including MRI in some cases, and consideration of alternative treatments like hCG or clomiphene that work by stimulating the axis rather than bypassing it.
What does it mean if my LH is high along with my testosterone being low?
High LH with low testosterone indicates primary hypogonadism -- the testes are receiving adequate stimulation but are not producing enough testosterone. The pituitary is working correctly; the problem is at the testicular level. Men with this pattern require exogenous testosterone replacement because stimulating the axis further will not improve testicular output.
Will testosterone therapy permanently suppress my own hormone production?
In the vast majority of men, HPG axis suppression from TRT is reversible after stopping therapy. Recovery of endogenous testosterone production and spermatogenesis typically occurs over 6 to 18 months. Longer duration of TRT use is associated with slower recovery. A small percentage of men, particularly older men or those with long-standing TRT, may not fully recover. This is one reason fertility preservation discussions are important before starting TRT in younger men.
Can the HPG axis be restarted after testosterone therapy?
Yes, in most men. The pituitary and hypothalamus retain their responsiveness to GnRH and the negative feedback loop. When exogenous testosterone is removed, the falling testosterone levels prompt the hypothalamus to resume GnRH pulsatility and the pituitary to resume LH and FSH secretion. Testicular stimulation then gradually restores endogenous production and, to varying degrees, spermatogenesis. This process is sometimes accelerated by post-cycle protocols using hCG or clomiphene, though these approaches are not universally endorsed in standard TRT management guidelines.
What This Means for Your Treatment Decisions
Understanding the HPG axis helps you ask better questions at your clinical evaluation. Your LH and FSH levels are not incidental -- they tell your provider whether your low testosterone is coming from the testes or from insufficient brain-pituitary signaling, and that distinction shapes which treatment options are appropriate for your situation.
Keen Meds connects you with licensed clinical providers for a telehealth evaluation and lab review. If your testosterone is clinically low, you may qualify for Testosterone Spray Rx.
